CEACAM5 and colorectal carcinoma: CTCs-positive patients had increased CA19-9 levels regardless of CEA levels (Figure 6D), suggesting that only the CA19-9 levels could serve as a potential marker for high CTCs in first reflux vein blood in non-metastatic CRC patients.